mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.5 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.5 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.5 |